论文信息 - Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer - 字舞流文

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer

W. Messersmith | C. Leichman | L. Leichman | C. Denlinger | P. Gold | D. Cohen | H. Hochster | N. Uboha | S. Cohen | B. ONeil | H. S. Hochster | P. J. Gold | C. G. Leichman